Sunlight review

On the question that is hardest to answer about any compounded-medication seller, who actually makes this and who signed for it, Sunlight gives a clear answer. It names six compounding pharmacies with phone numbers, its medical group and two prescribing physicians with their NPI numbers, and it displays a LegitScript seal. Sermorelin and NAD⁺ are each $159 a month at every dose, and required labs are free through its partner labs. Two things undercut the "no hidden fees" promise and the sales pages. Its help center says cancellations after a clinician has reviewed your file carry an $80 clinical fee. And its NAD⁺ page is the weakest page on its own site: wrong molecular class, a supplement-style disclaimer, and an oversight paragraph crediting a different brand.

A telehealth platform run by GLP-1 LLC of Seattle, Washington, whose core business is compounded GLP-1 weight loss, with compounded NAD⁺ and sermorelin as a newer secondary line built on the same sign-up flow. NAD⁺ ships as a ready-to-use liquid for injection under the skin; sermorelin (sermorelin acetate, with mannitol as the inactive ingredient) ships as a freeze-dried powder with bacteriostatic water for mixing. Each plan is a four-week supply shipped every month. There is no testosterone product, so it is not covered here as a TRT provider. Coverage is every US state except Mississippi, with a waitlist offered otherwise.

Asynchronous-first with a conditional synchronous step, which the site explains honestly: appointments are required only in certain situations, such as when your medical history needs further review or the medication requires closer monitoring, and not all patients will need to meet a provider. A virtual visit, when triggered, is booked after intake and checkout. Labs are mandatory but deferred: all patients must complete testing (typically A1c, TSH, a metabolic panel and a lipid panel) before their third prescription is issued, some intakes require them sooner, results from the past 24 months are accepted, and there is no extra cost if you test through its partner labs, LabCorp, Quest or BioReference. Pricing is public before signup. Each month brings a four-week supply with injection supplies, temperature-controlled shipping and access to the care team. The disclosure is the reason to take Sunlight seriously: it names six compounding pharmacies with their phone numbers, and names its medical group, Lion MD, and two physicians, Dr. Ana Lisa Carr and Dr. Kelly Tenbrink, with their NPI numbers. The cancellation terms are the catch. The sales pages promise "Cancel Anytime" and "No Hidden Fees", but the help center's refund and cancellation articles say a cancellation requested after a clinician has reviewed your intake, history or monthly check-in carries an $80 clinical fee, waived only if the clinician finds the medication unsuitable. You get a full refund only if you cancel before that review, and nothing back once a prescription has gone to the pharmacy. Cancellation is by phone (8 a.m. to 8 p.m. Eastern, seven days) or portal message. The membership language also contradicts itself: every badge reads "No Monthly Membership" while the NAD⁺ questions and answers refer to canceling your "membership".

Simple on the surface. Sermorelin and NAD⁺ are each "Starting at $159" a month, with "Same price for every dose", on both product pages, and the price includes the telehealth consultation, the medication, injection supplies and free shipping, with no commitment tier and no membership fee. The help center says the monthly payment stays the same and covers everything, and that required labs cost nothing extra through its partner labs. The GLP-1 side runs a fall promotion from $88 for compounded semaglutide and $157 for tirzepatide. Three things to price in. First, the $80 clinical fee on cancellations after a clinician review, which sits in the help center rather than on the product pages. Second, no per-dose or per-vial breakdown is published, so you cannot see how much NAD⁺ or sermorelin $159 buys. Third, the refund policy mentions multi-month bundles, but no bundle price is shown for either peptide.

Compounded; not FDA-approved. Sunlight says so in the questions and answers on both product pages and in every peptide help-center article, and its comparison tables steer readers away from gray-market "research peptides". Its product documentation is deep: fifteen help-center articles covering ingredients, reconstitution, dosing, storage, sourcing and side effects, with the sermorelin formulation's inactive ingredient named. The fine print at the foot of both product pages is weaker: each ends with the dietary-supplement formula, "These statements have not been evaluated by the Food and Drug Administration", on a page selling a prescription compounded drug. Two further faults sit on the NAD⁺ page specifically. It calls the product "a single daily peptide"; NAD⁺ is a dinucleotide coenzyme, not a peptide, which is simply the wrong molecular class. And its medical-oversight paragraph states that treatment is "provided through Direct Meds", a different company, on the one paragraph whose job is to establish who is responsible for your care; the sermorelin page's version of the same paragraph correctly says Sunlight. Its reference list also cites a resveratrol paper dated 1996, a year that literature does not have. On the evidence: injected NAD⁺ has no controlled human outcome trials, and the page's claims of roughly 100% bioavailability and results felt within days carry no citation. Sermorelin is positioned more defensibly, as an adjunct during rapid GLP-1 weight loss with the goal of supporting muscle retention. Individual results vary.